Mixed urinary incontinence: international urogynecological association research and development committee opinion

Int Urogynecol J. 2014 Oct;25(10):1303-12. doi: 10.1007/s00192-014-2485-8. Epub 2014 Aug 5.

Abstract

Background and aim: The definition as well as the treatment of women with mixed urinary incontinence (MUI) is controversial. Since women with MUI are a heterogeneous group, the treatment of MUI requires an individual assessment of the symptom components: stress urinary incontinence, urinary urgency, urgency urinary incontinence, urinary frequency, and nocturia. The purpose of this paper is to summarize the current literature and give an evidence-based review of the assessment and treatment of MUI.

Methods: A working subcommittee from the International Urogynecological Association (IUGA) Research and Development (R&D) Committee was formed. An initial document addressing the diagnosis and management of MUI was drafted based on a literature review. After evaluation by the entire IUGA R&D Committee, revisions were made, and the final document represents the IUGA R&D Committee Opinion on MUI.

Results: This R&D Committee Opinion reviews the literature on MUI and summarizes the assessment and treatment with evidence-based recommendations.

Conclusions: The diagnosis of MUI encompasses a very heterogeneous group of women. The evaluation and treatment requires an individualized approach. The use of validated questionnaires is recommended to assess urinary incontinence symptoms and effect on quality of life. Conservative therapy is suggested as a first-line approach; if surgery is contemplated, urodynamic investigation is recommended. Women undergoing surgical treatment for MUI need to be counselled about the possibility of persistence of urinary urgency, frequency and urge incontinence even if stress urinary incontinence is cured.

Publication types

  • Review

MeSH terms

  • Acrylic Resins / therapeutic use
  • Female
  • Gynecological Examination
  • Humans
  • Hydrogels / therapeutic use
  • Neurotransmitter Agents / therapeutic use
  • Quality of Life
  • Suburethral Slings
  • Urinalysis
  • Urinary Incontinence, Urge / diagnosis*
  • Urinary Incontinence, Urge / etiology
  • Urinary Incontinence, Urge / therapy*
  • Urinary Sphincter, Artificial
  • Urodynamics

Substances

  • Acrylic Resins
  • Bulkamid
  • Hydrogels
  • Neurotransmitter Agents